Pfizer Inc (PFE)
25.98
+0.60
(+2.34%)
USD |
NYSE |
Apr 19, 16:00
25.92
-0.06
(-0.25%)
After-Hours: 20:00
Pfizer Shareholders Equity (Quarterly): 89.01B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 89.01B |
September 30, 2023 | 96.93B |
June 30, 2023 | 99.02B |
March 31, 2023 | 100.97B |
December 31, 2022 | 95.66B |
September 30, 2022 | 92.63B |
June 30, 2022 | 87.21B |
March 31, 2022 | 82.42B |
December 31, 2021 | 77.20B |
September 30, 2021 | 75.69B |
June 30, 2021 | 70.04B |
March 31, 2021 | 68.62B |
December 31, 2020 | 63.24B |
September 30, 2020 | 65.26B |
June 30, 2020 | 64.34B |
March 31, 2020 | 65.03B |
December 31, 2019 | 63.14B |
September 30, 2019 | 65.10B |
June 30, 2019 | 59.57B |
March 31, 2019 | 58.81B |
December 31, 2018 | 63.41B |
September 30, 2018 | 71.32B |
June 30, 2018 | 69.78B |
March 31, 2018 | 70.18B |
December 31, 2017 | 71.31B |
Date | Value |
---|---|
September 30, 2017 | 60.77B |
June 30, 2017 | 58.37B |
March 31, 2017 | 58.44B |
December 31, 2016 | 59.54B |
September 30, 2016 | 63.31B |
June 30, 2016 | 62.77B |
March 31, 2016 | 63.07B |
December 31, 2015 | 64.72B |
September 30, 2015 | 66.84B |
June 30, 2015 | 66.89B |
March 31, 2015 | 67.30B |
December 31, 2014 | 71.30B |
September 30, 2014 | 77.99B |
June 30, 2014 | 76.63B |
March 31, 2014 | 77.77B |
December 31, 2013 | 76.31B |
September 30, 2013 | 77.97B |
June 30, 2013 | 78.55B |
March 31, 2013 | 82.25B |
December 31, 2012 | 81.26B |
September 30, 2012 | 81.70B |
June 30, 2012 | 79.55B |
March 31, 2012 | 83.26B |
December 31, 2011 | 82.19B |
September 30, 2011 | 90.05B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
59.57B
Minimum
Jun 2019
100.97B
Maximum
Mar 2023
77.95B
Average
75.69B
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 6.232B |
Gilead Sciences Inc | 22.83B |
Johnson & Johnson | 68.77B |
Viking Therapeutics Inc | 348.42M |
Moderna Inc | 13.85B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 226.50B |
Total Liabilities (Quarterly) | 137.21B |
Debt to Equity Ratio | 0.7959 |
Current Ratio | 0.9067 |
Net Debt Paydown Yield | -4.33% |